Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Haemophilia A and B With and Without Inhibitors”

19 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 19 of 19 results

Early research (Phase 1)Study completedNCT01949792
What this trial is testing

A Trial Investigating the Pharmacokinetics and Pharmacodynamics of rFVIIa in Patients With Haemophilia A or B With or Without Inhibitors

Who this might be right for
Congenital Bleeding DisorderHaemophilia AHaemophilia A With Inhibitors+2 more
Novo Nordisk A/S 6
Testing effectiveness (Phase 2)Study completedNCT04073498
What this trial is testing

The Safety and Tolerability of SerpinPC in Healthy Men and in Men with Severe Blood Disorders (haemophilia a and B)

Who this might be right for
Hemophilia aHemophilia B
ApcinteX Ltd 39
Large-scale testing (Phase 3)Study completedNCT03417245
What this trial is testing

Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients Without Inhibitors

Who this might be right for
Hemophilia AHemophilia B
Genzyme, a Sanofi Company 120
Testing effectiveness (Phase 2)Ended earlyNCT03597022
What this trial is testing

Multiple Escalating Dose Study of BAY1093884 in Adults With Hemophilia A or B With or Without Inhibitors

Who this might be right for
Hemophilia A and B
Bayer 24
Early research (Phase 1)Study completedNCT02571569
What this trial is testing

A Single Escalating Dose and Multiple Dose Study of BAY 1093884 in Subjects With Severe Hemophilia Types A or B, With or Without Inhibitors

Who this might be right for
Hemophilia AHemophilia B
Bayer 32
Large-scale testing (Phase 3)Looking for participantsNCT07545395
What this trial is testing

Safety of KN057 Prophylaxis in Patients With Haemophilia A or B

Who this might be right for
Hemophilia A or B
Suzhou Alphamab Co., Ltd. 70
Large-scale testing (Phase 3)Active Not RecruitingNCT04082429
What this trial is testing

Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia Without Inhibitors

Who this might be right for
Haemophilia A Without InhibitorsHaemophilia B Without Inhibitors
Novo Nordisk A/S 156
Large-scale testing (Phase 3)Active Not RecruitingNCT05135559
What this trial is testing

A Research Study on How Well Concizumab Works for You if You Have Haemophilia A or B With or Without Inhibitors

Who this might be right for
Haemophilia A and B With and Without Inhibitors
Novo Nordisk A/S 153
Large-scale testing (Phase 3)Looking for participantsNCT05145127
What this trial is testing

Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors

Who this might be right for
Hemophilia AHemophilia B
Pfizer 245
Early research (Phase 1)Study completedNCT01921855
What this trial is testing

Study of FVIIa Variant BAY86-6150 (B0189) in Subjects With Moderate or Severe Hemophilia Types A or B With or Without Inhibitors

Who this might be right for
Hemophilia AHemophilia B
Bayer 16
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06747416
What this trial is testing

KN057 Multiple Dose Study in Patients with Hemophilia a or Hemophilia B with or Without Inhibitors

Who this might be right for
Hemophilia a and B
Suzhou Alphamab Co., Ltd. 24
Testing effectiveness (Phase 2)Study completedNCT05421429
What this trial is testing

KN057 Multiple Dose Study in Moderately Severe to Severe Hemophilia

Who this might be right for
Hemophilia
Suzhou Alphamab Co., Ltd. 24
Early research (Phase 1)Study completedNCT01439971
What this trial is testing

Phase 1 Safety, Pharmacokinetics And Pharmacodynamics Study Of Recombinant Factor VIIa Variant (813d) In Adult Subjects With Hemophilia

Who this might be right for
Hemophilia A
Catalyst Biosciences 29
Large-scale testing (Phase 3)Study completedNCT03938792
What this trial is testing

Study of the Efficacy and Safety PF-06741086 in Adult and Teenage Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B

Who this might be right for
Hemophilia AHemophilia B
Pfizer 189
Large-scale testing (Phase 3)Looking for participantsNCT05611801
What this trial is testing

A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B

Who this might be right for
Hemophilia AHemophilia B
Pfizer 100
Not applicableStudy completedNCT03741881
What this trial is testing

A Study Following People With Haemophilia A and B, With or Without Inhibitors, When on Usual Treatment (Explorer™6)

Who this might be right for
Haemophilia AHaemophilia A With InhibitorsHaemophilia B+1 more
Novo Nordisk A/S 231
Large-scale testing (Phase 3)Active Not RecruitingNCT06569108
What this trial is testing

Efficacy and Safety of KN057 Prophylaxis in Patients With Haemophilia A or B Without Inhibitors

Who this might be right for
Hemophilia A Without InhibitorHemophilia B Without Inhibitor
Suzhou Alphamab Co., Ltd. 125
Not applicableStudy completedNCT03596814
What this trial is testing

MOTHIF II : THERAPEUTIC MANAGEMENT AND USE OF CLOTTING FACTORS IN HEMOPHILIA A & B IN FRANCE II

Who this might be right for
Hemophilia
Nantes University Hospital 2,072
Not applicableEnrolling By InvitationNCT06831734
What this trial is testing

Post-marketing Surveillance (Special Use-results Surveillance) on Treatment With Alhemo

Who this might be right for
Haemophilia A, Haemophilia B
Novo Nordisk A/S 30